 | Up a level |
Number of items: 1.
Stilgenbauer, S., Schleinitz, T. Aurran, Hallek, M., Lang, F., Offner, F., Rossi, J. -F., Schroyens, W., Van Den Neste, E., Ysebaert, L., Blum, P., Hocke, J., Kress, U. U. and Zenz, T. (2015). PHASE I, FIRST-IN-HUMAN TRIAL OF BI 836826 (AN ANTI-CD37 ANTIBODY) IN PATIENTS (PTS) WITH RELAPSED/REFRACTORY (R/R) CHRONIC LYMPHOCYTIC LEUKEMIA (CLL). Haematologica, 100. S. 225 - 227. PAVIA: FERRATA STORTI FOUNDATION. ISSN 0390-6078